A/APublished research associates this genotype with typical/baseline likelihood of Basal cell carcinoma — no copies of the reported risk allele. (GWAS Catalog, Genome Med 2021, PMID:33549134)
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Basal cell carcinoma. (GWAS Catalog, Genome Med 2021, PMID:33549134)
G/GPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Basal cell carcinoma compared to the general population. (GWAS Catalog, Genome Med 2021, PMID:33549134)
Source: GWAS Catalog, Genome Med 2021, PMID:33549134
Questions about rs9392026
What is rs9392026?
rs9392026 is a single position in the genome, in or near the EXOC2 gene. Published research associates it with basal cell carcinoma. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs9392026 linked to?
On MyGeneLog this position is linked to Basal Cell Carcinoma. The research behind each link, and its sources, are set out on that condition page.
Does having rs9392026 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs9392026 come from?
GWAS Catalog, Genome Med 2021, PMID:33549134. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.